1
ALL1
Turn TherapeuticsYear
1
ALL1
2021DEALS // DEV.
1
ALL1
DevelopmentsCountry
1
ALL1
U.S.A1
ALL1
Not ApplicableTherapeutic Area
1
ALL1
Infections and Infectious DiseasesStudy Phase
1
ALL1
UndisclosedDeal Type
0
ALLProduct Type
1
ALL1
Small moleculeDosage Form
1
ALL1
IntranasalLead Product
1
ALL1
PetrolatumTarget
0
ALLLead Product(s) : Petrolatum
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Turn Therapeutics Receives Authorization to Commence Human Trial for COVID-19 Therapeutic Candidate
Details : Hexagen contains broad-spectrum, liquid antimicrobials with strong antiviral activity suspended in petrolatum. The trial will assess Hexagen’s ability to prevent COVID-19 infection in frontline workers when worn intranasally as an adjunct to personal p...
Product Name : Hexagen
Product Type : Small molecule
Upfront Cash : Not Applicable
January 21, 2021
Lead Product(s) : Petrolatum
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable